Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $365.53 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $125.00 | 1 | $0 (2019) |
| Allergan, Inc. | $81.37 | 1 | $0 (2020) |
| ABBVIE INC. | $69.42 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $42.42 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.19 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $15.13 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.47 | 5 | ABBVIE INC. ($69.42) |
| 2023 | $34.69 | 2 | Novartis Pharmaceuticals Corporation ($19.56) |
| 2020 | $81.37 | 1 | Allergan, Inc. ($81.37) |
| 2019 | $125.00 | 1 | United Therapeutics Corporation ($125.00) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/29/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: COVID-19 | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/18/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $81.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2019 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PAH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 582 | 956 | $205,089 | $74,776 |
| 2022 | 10 | 636 | 969 | $147,068 | $62,294 |
| 2021 | 7 | 249 | 445 | $60,931 | $26,609 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 175 | 369 | $85,227 | $33,612 | 39.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 157 | 306 | $47,794 | $18,383 | 38.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 145 | 155 | $41,078 | $13,407 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 40 | $18,898 | $5,178 | 27.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 44 | 44 | $8,230 | $2,595 | 31.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 42 | $3,862 | $1,601 | 41.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 148 | 348 | $44,284 | $18,413 | 41.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 222 | $39,348 | $16,776 | 42.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 106 | 108 | $19,676 | $8,460 | 43.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $9,128 | $4,617 | 50.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 79 | 83 | $10,359 | $4,215 | 40.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 34 | 49 | $6,664 | $2,561 | 38.4% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 26 | 30 | $6,060 | $2,194 | 36.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 40 | 40 | $4,984 | $2,056 | 41.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $3,455 | $1,724 | 49.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 44 | $3,110 | $1,277 | 41.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 80 | 216 | $27,528 | $11,809 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 65 | $11,660 | $5,016 | 43.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 44 | 44 | $5,516 | $2,396 | 43.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $4,373 | $2,284 | 52.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 24 | 25 | $4,586 | $2,008 | 43.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 30 | 30 | $3,732 | $1,634 | 43.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 50 | $3,536 | $1,463 | 41.4% |
About Dr. Aadil Ahmed, DO
Dr. Aadil Ahmed, DO is a Hospitalist healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1528550357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aadil Ahmed, DO has received a total of $365.53 in payments from pharmaceutical and medical device companies, with $124.47 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($365.53).
As a Medicare-enrolled provider, Ahmed has provided services to 1,467 Medicare beneficiaries, totaling 2,370 services with total Medicare billing of $163,679. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Saint Joseph, MO
- Active Since 06/06/2018
- Last Updated 07/29/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1528550357
Products in Payments
- ORENITRAM (Drug) $125.00
- UBRELVY (Drug) $81.37
- DALVANCE (Drug) $44.89
- LEQVIO (Drug) $42.42
- GLASSIA (Biological) $32.19
- TEFLARO (Drug) $24.53
- Veklury (Drug) $15.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Saint Joseph
Allison Roe, D.o, D.O
Hospitalist — Payments: $1,062
Dr. Steffan Libarnes, M.d, M.D
Hospitalist — Payments: $777.57
Michael Wang, Md, MD
Hospitalist — Payments: $632.14
Nafis Islam, Md, MD
Hospitalist — Payments: $616.46
Daniel Bosis, M.d, M.D
Hospitalist — Payments: $381.62
Dr. Amulya Dakka, Md, MD
Hospitalist — Payments: $292.64